...Russia — May 2002. MMWR Morb Mortal Wkly Rep 2002;51:394-5. [50] Whitney CG. Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after...protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-46. [51] Hendley JO, Sande MA, Stewart PM, et al. Spread oí Streptococcus pneumoniae...

...Schuchat, A.; Active Bacterial Core Surveillance of the Emerging Infections Program Network. (2003). Decline in invasive pneumococcal disease after the...protein-polysaccharide conjugate vaccine. N. EngL J. Med. 348,1737. Congenital Syphilis Resurgent Simon Dobson 1. Introduction 7 It is almost a century since the Wassermann...

...JH, Schuchat, A.; Active Bacterial Core Surveillance of the Emerging Infections Program Network 2003. Decline in invasive pneumococcal disease after the...protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348: 1737-1746. Wright, SD, Ramos, RA, Tobias, PS, Ulevitch, RJ, and Mathison, JC 1990. CD14. a receptor...

...Hadler J, et al, for the Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the...introduction of protein-polysaccharide conjugate vaccine. N Enel J Med. 2003;348: 1737-1746. 156 Second-Line and Third-Line Antibiotic Therapy Second- or third-line...

...Infect Dis 2000; 182:970-973. 58. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after...proteinpolysaccharide conjugate vaccine. N Engl J Med 2003; 348:1737-1746. 59. American Thoracic Society; Infectious Diseases Society of America. Guidelines...

...MM. Hadler J, et al; Active Bacterial Core Surveillance of the Emerging lnfections Program Network: Decline in invasive pneumococcal disease after the...proteinpolysaccharide conjugate vaccine. N Engl J Med 348:1737-1746, 2003. 114. ¿Cuáles son las indicaciones pediátricas para la vacuna frente a la gripe?...

...the United States in 1995. N Engl J Med 337:970-976 3. Whitney CG, Farley MM, Hadler MM et al (2003) Decline in invasive pneumococcal disease after the...protein-polysaccharide conjugate vaccine. N Engl J Med 348:1737-1746 5. Flores-Cordero JM, Amaya-Villar R, Rincon-Ferrari MD et al (2003) Acute community-acquired...

...1994:154:2666-77. 103. Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the...introduction of protein-polysaccharide conjugate vaccine. N EnglJ Med. 2003:348:1737-46. 104. Active Bacterial Core Surveillance Team. Changing epidemiology of...

...preventive measures are not being followed. / din Pathol. 2001;54:214-218. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after...protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-1746. World Health Organization. Guidelines for the Treatment of Malaria. Geneva, Switzerland:...

...expanded, pivotal role for LPS binding protein. Immunity 2003;19:269-79. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after...protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-46. Xiao C, Ghosh S. NF-kappaB, an evolutionarily conserved mediator of immune and inflammatory...